Dementia Assessment Notes

Purpose of Assessment

  • Very early stages: Differentiate between normal aging and pathological cognitive decline.

  • Obvious symptom stages: Identify specific strengths/weaknesses, determine etiology (e.g., nNCD/AD/PD), and establish treatment goals.

  • Later stages: Monitor the degree of disease progression.

General Considerations and Medical Review

  • Screening: Evaluate basic sensory and cognitive functions.

  • Interviewing: Engaging caregivers is essential for a thorough clinical picture.

  • Dynamic Assessment: Observe the client’s learning potential and response to various cues.

  • Medical Records: Review medication lists, risk factors (age, education, family history, history of strokes), and the impact of deficits on daily life.

Medical Screening Tools

  • Global Deterioration Scale (GDS; Reisberg, et al., 1982): A crude rating scale used to track deterioration over time; it is not sensitive to mild cognitive changes.

  • Mini Mental State Exam (MMSE): A brief tool requiring no specialized training, typically lasting 10−20 minutes10-20\,\text{minutes}, used to determine if an SLP referral is necessary.

SLP Screening Tools

  • Montreal Cognitive Assessment (MoCA): A ≈10 minute\approx 10\,\text{minute} test designed to detect mNCD; it is more sensitive than the MMSE, particularly for patients who score normally on the latter.

  • St. Louis University Mental Status (SLUMS): Equivalent in sensitivity to the MoCA and superior to the MMSE; originally designed for veterans and used to detect mNCD in ≈10 minutes\approx 10\,\text{minutes}.

Comprehensive Standardized Tests

  • Alzheimer’s Disease Assessment Scale-Cognition (ADAS-Cog): A comprehensive 30−45 minute30-45\,\text{minute} test that quantifies dysfunction across subtests including word recall, ideational praxis, orientation, and language.

  • Arizona Battery for Communication Disorders of Dementia (ABCD): Evaluates severity, dementia type, and therapy targets through subtests on verbal memory, mental status, and visuospatial skills.

Functional and Quality of Life Assessments

  • Functional Independence Measure (FIM): Measures physical and cognitive disability.

  • Instrumental Activities of Daily Living (IADL): Assesses complex tasks like shopping, housekeeping, and finances.

  • Alzheimer’s Disease-specific Quality of Life Scale (QoL-AD): Completed by either the patient or caregiver to evaluate quality of life across all severity levels.

Specialized Domain Testing

  • Verbal Memory: Includes the California Verbal Learning Test (CVLT), verbal span (digits, words, phrases, telephone test), and auditory-verbal working memory (WM) such as digits backwards (Tompkins et al., 1994).

  • Nonverbal Memory: Includes Rey’s Visual Design Learning Test, Continuous Visual Memory Test (for motor problems), and the Location Learning Test.

  • Communication and Language: Batteries include the BDAE, WAB, and Communicative Abilities in Daily Living (CADL) to assess linguistic expression, comprehension, and communicative strengths.